Avascular Necrosis of Bone Complicating Treatment of Malignant Lymphoma: Report of 6 cases.
- Author:
Hyung Chan SUH
1
;
Jee Sook HAHN
;
Bum Seok KIM
;
Seok LEE
;
So Young CHONG
;
Yoo Hong MIN
;
Yun Woong KO
Author Information
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Avascular necrosis;
Malignant lymphoma;
Steroid
- MeSH:
Arthroplasty, Replacement, Hip;
Diagnosis;
Drug Therapy;
Early Diagnosis;
Hip Joint;
Hodgkin Disease;
Humans;
Joints;
Lymphoma*;
Lymphoma, Non-Hodgkin;
Magnetic Resonance Imaging;
Necrosis;
Osteonecrosis*;
Prednisolone;
Weight-Bearing
- From:Journal of the Korean Cancer Association
1997;29(2):344-351
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Several reports have documented the association of avascular necrosis (AVN) of bone and the treatment of malignant lymphoma with steroid-containing chemotherapy. It is important to recognize these conditions, as they can be mistaken for those of lymphomatous involvement.Cases: This report describes the experience at the Severance hospital over a 10-year period with 6 patients in whom AVN developed during or following treatment of malignant lymphoma. Four patients of non-Hodgkin's lymphoma and two of Hodgkin's disease were treated with steroid-containing chemotherapy. The predominant symptom is pain on motion or weight bearing. Symptoms leading to diagnosis of AVN developed between 5 and 27 months after starting prednisolone (mean 17.8 months), and the mean cumulative dose of prednisolone to the onset of AVN was 4,447 mg (range, 1,800~9,490 mg). All but one were involved in both hip joint. Diagnosis was based on the radiologic appearance, and in the majority radiographic changes consistent with AVN were present at the time of presentation of symptoms. Four patients received total hip replacement and two had conservative care. CONCLUSION: Patients with malignant lymphoma who developed pain on joint during or after the use of steroid-containing chemothearpy should be carefully investigated with MRI and radionuclear bone scan for early diagnosis and proper management.
